When was the last time you had your breast cancer screening?

Breast cancer is the most common type of cancer in women after skin cancer. It is the second most common cause of death from cancer after lung cancer.

Every woman is at risk in proportion to increasing age. In general, a woman’s lifetime (90 years) risk of developing breast cancer is 1 in 8 women. This rate is valid for the general population and this rate may increase according to risk factors. It is not possible to prevent breast cancer with today’s medical information. However, technology provides us with very powerful tools for early diagnosis.

“Scan inspection” It is the examination performed to detect cancer before the person develops any complaints or examination findings. The aim is to detect cancer at an early stage and to use the easiest and most effective treatment opportunity possible. Studies show that early diagnosis and effective treatment methods reduce breast cancer mortality rates by up to 30%.

Breast cancer risk factors ; being female, advanced age, having menstruation at an early age, entering late menopause, giving birth late (over 30 years old) or having never given birth, history of breast cancer diagnosed in the past or benign breast disease that has been biopsied, mother or sister presence of breast cancer, having received radiation therapy involving the breast or chest wall, having received hormone therapy containing estrogen and progesterone, excessive weight gain after menopause, and the presence of a dense breast pattern on mammography. In cases where the risk of breast cancer increases, the breast cancer screening program should be determined individually with the patient’s physician.

mammography It is an indispensable method for breast cancer screening. Early breast cancer findings are evaluated in mammography. In mammography examination, bilateral radiographs of both breasts are taken as standard. During the examination, the breast is compressed to thin the breast tissue and separate the overlapping tissues from each other. During compression, sensitivity may vary from person to person, but the compression process is done at the highest degree allowed by the patient in order to ensure the reliability and diagnostic value of the mammography examination. This time is limited to seconds and there is no damage to the breast tissue or the spread of possible diseases.

The risk of developing breast cancer due to X-rays used during mammography is within medically negligible limits with the new technologies used. Compared to the expected benefits of mammography, the potential risk associated with X-rays is negligible. By keeping the amount of rays given in high-tech digital mammography devices as low as possible,

It is aimed to reduce the possible risks related to X-ray.

The reliability of mammography in detecting breast cancer can be as low as 60-70% depending on the density of the breast tissue. However, digital mammography devices have high reliability and diagnostic value in detecting lesions, especially in young people with dense breast tissue.

Breast ultrasonography is used as an auxiliary method in order to minimize the limitations of mammography in people with dense breast structure. Since ultrasonography works with sound waves, it does not pose any risk. However, it is not an adequate method for breast cancer screening alone.

The recommended breast cancer screening program starts with one baseline examination between the ages of 35 and 40. This examination is a reference and is important for comparing subsequent examinations. Mammographic annual controls start from the age of 40 and should be done regularly every year. In some countries, screening is carried out every two or three years, but this plan reflects the countries’ resource planning and screening programs that involve the whole population. The recommendation of professional organizations is on an annual control basis. While determining the control intervals, it is aimed to detect the lesions that may occur between the examinations without changing the stage. Two- or three-year follow-up intervals lead to staging of lesions and, consequently, to a reduced chance of early diagnosis. However, within the framework of a personalized medicine approach, the appropriate screening method for each patient should be discussed with the patient, taking into account breast density, patient age and risk factors.

Considering the extended life expectancy, the controls are continued as long as the patient does not have any other life-threatening health problems, regardless of age, and if the patient can go to the examination.

In breast cancer screening, clinical breast examination by the physician related to breast diseases is an integral part of the screening. Breast examination is recommended every three years between the ages of 20-39 and once a year from the age of 40.

Related Posts

Leave a Reply

Your email address will not be published.